(Q34319457)

1 August 2017

title

Synthesis and characterization of a hypoxia-sensitive MRI probe (English)

1 reference

1 August 2017

0 references

4

Zsolt Baranyai

1 reference

1 August 2017

11

A Dean Sherry

2 references

ORCID Public Data File 2021

1 August 2017

Federico A Rojas-Quijano

1

object named as

Federico A Rojas-Quijano

1 reference

1 August 2017

6

Ferenc K Kálmán

1 reference

1 August 2017

3

Enikő Tircsóné Benyó

1 reference

1 August 2017

Gyula Tircsó

2

1 reference

1 August 2017

Huan Tran Hoang

5

1 reference

1 August 2017

Praveen K Gulaka

7

1 reference

1 August 2017

Vikram D Kodibagkar

8

1 reference

1 August 2017

Silvio Aime

9

1 reference

1 August 2017

Zoltán Kovács

10

1 reference

1 August 2017

language of work or name

English

0 references

publication date

27 June 2012

1 reference

Chemistry—A European Journal

1 August 2017

published in

1 reference

1 August 2017

volume

18

1 reference

1 August 2017

issue

31

1 reference

1 August 2017

page(s)

9669-9676

1 reference

Synthesis of 68Ga-labeled DOTA-nitroimidazole derivatives and their feasibilities as hypoxia imaging PET tracers

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518072

Gallium(III) complexes of DOTA and DOTA-monoamide: kinetic and thermodynamic studies.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518072

Alternatives to gadolinium-based metal chelates for magnetic resonance imaging

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518072

Synthesis and Characterization of DOTA-(amide)(4) Derivatives: Equilibrium and Kinetic Behavior of Their Lanthanide(III) Complexes.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518072

The synthesis and chelation chemistry of DOTA-peptide conjugates

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518072

Review: implications of in vitro research on the effect of radiotherapy and chemotherapy under hypoxic conditions.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518072

Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518072

In vitro and in vivo magnetic resonance detection of tumor cells by targeting glutamine transporters with Gd-based probes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518072

Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518072

Preparation and preliminary biological evaluation of a 177Lu labeled sanazole derivative for possible use in targeting tumor hypoxia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518072

A phase I study of SR-4554 via intravenous administration for noninvasive investigation of tumor hypoxia by magnetic resonance spectroscopy in patients with malignancy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518072

Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518072

Combination of the bioreductive drug tirapazamine with the chemotherapeutic prodrug cyclophosphamide for P450/P450-reductase-based cancer gene therapy.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518072

NMR studies of the metal-loading kinetics and acid-base chemistry of DOTA and butylamide-DOTA.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518072

Nitroimidazole drugs-action and resistance mechanisms I. Mechanism of action

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518072

Hypoxia-selective antitumor agents. 8. Bis(nitroimidazolyl)alkanecarboxamides: a new class of hypoxia-selective cytotoxins and hypoxic cell radiosensitisers.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518072

The novel fluorinated 2-nitroimidazole hypoxia probe SR-4554: reductive metabolism and semiquantitative localisation in human ovarian cancer multicellular spheroids as measured by electron energy loss spectroscopic analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518072

Interaction of nitroimidazole drugs with DNA in vitro: structure-activity relationships

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518072

Radiosensitization of C3H mouse mammary tumours by a 2-nitroimidazole drug

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518072

Demonstration of tumor-selective retention of fluorinated nitroimidazole probes by 19F magnetic resonance spectroscopy in vivo

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518072

Structure-activity relationships in the development of hypoxic cell radiosensitizers. I. Sensitization efficiency

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518072

Lanthanide(III) complexes of DOTA-glycoconjugates: a potential new class of lectin-mediated medical imaging agents.

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCHEM.201200266

Predicting the effect of temporal variations in PO2 on tumor radiosensitivity

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCHEM.201200266

High sensitivity lanthanide(III) based probes for MR-medical imaging

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCHEM.201200266

In vitro and in vivo evaluation of a technetium-99m-labeled 2-nitroimidazole (BMS181321) as a marker of tumor hypoxia

21 January 2018

1 reference

12 December 2020

A radiosynthesis of fluorine-18 fluoromisonidazole

1 reference

12 December 2020

The stability of the metal complexes of cyclic tetra-aza tetra-acetic acids

1 reference

12 December 2020

Structure of Azomycin, a new antibiotic

1 reference

12 December 2020

Bromomisonidazole: synthesis and characterization of a new radiosensitizer

1 reference

12 December 2020

Selective Radiosensitization of the Hypoxic Cells of Mouse Tumors with the Nitroimidazoles Metronidazole and Ro 7-0582

1 reference

12 December 2020

Partition coefficient as a guide to the development of radiosensitizers which are less toxic than misonidazole

1 reference

12 December 2020

Identifiers

DOI

10.1002/CHEM.201200266

1 reference

1 August 2017

1 reference

1 August 2017

1 reference